These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7587022)

  • 1. Cefotaxime use in pediatric infections.
    Dajani AS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.
    McCracken GH; Nelson JD; Kaplan SL; Overturf GD; Rodriguez WJ; Steele RW
    Pediatr Infect Dis J; 1987 Jun; 6(6):501-5. PubMed ID: 3615064
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate.
    Flórez C; Silva G; Martín E
    Pediatr Infect Dis J; 1996 Aug; 15(8):723-4. PubMed ID: 8858688
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging role of cephalosporins in bacterial meningitis.
    Nelson JD
    Am J Med; 1985 Aug; 79(2A):47-51. PubMed ID: 3849260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review and reassessment of dosing schedules for cefotaxime in selected medical indications.
    Young LS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):147-54. PubMed ID: 7587030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious pediatric infections.
    Kaplan SL
    Am J Med; 1990 Apr; 88(4A):18S-24S. PubMed ID: 2183605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
    Jacobs RF; Kaplan SL; Schutze GE; Dajani AS; Leggiadro RJ; Rim CS; Puri SK
    Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephalosporins--cefotaxime 10 years later, a major drug with continued use.
    Neu HC
    Infection; 1991; 19 Suppl 6():S309-15. PubMed ID: 1791075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
    Olivier C; Cohen R; Begué P; Floret D
    Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Heel RC
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
    Chesney PJ; Davis Y; English BK; Wang WC
    Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic options for cefotaxime in the management of bacterial infections.
    Raddatz JK; Ostergaard BE; Rotschafer JC
    Diagn Microbiol Infect Dis; 1995; 22(1-2):77-83. PubMed ID: 7587054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing incidence of penicillin- and cefotaxime-resistant
    Verghese VP; Veeraraghavan B; Jayaraman R; Varghese R; Neeravi A; Jayaraman Y; Thomas K; Mehendale SM
    Indian J Med Microbiol; 2017; 35(2):228-236. PubMed ID: 28681811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous cefotaxime in children with bacterial meningitis.
    Belohradsky BH; Bruch K; Geiss D; Kafetzis D; Marget W; Peters G
    Lancet; 1980 Jan; 1(8159):61-3. PubMed ID: 6101414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group.
    Peltola H; Anttila M; Renkonen OV
    Lancet; 1989 Jun; 1(8650):1281-7. PubMed ID: 2566824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cefotaxime in the treatment of surgical infections.
    Wittmann DH
    Diagn Microbiol Infect Dis; 1995; 22(1-2):173-82. PubMed ID: 7587036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningitis by Streptococcus pneumoniae: resistant to cefotaxime?].
    Fernández-Fernández FJ; García-Rodríguez JF; Sesma P; González-González C
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):45-6. PubMed ID: 10069118
    [No Abstract]   [Full Text] [Related]  

  • 20. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.
    Viladrich PF; Cabellos C; Pallares R; Tubau F; Martínez-Lacasa J; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 1996 Jan; 40(1):218-20. PubMed ID: 8787909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.